BIO/MED INVESTOR NETWORK Portfolio

 

Neocis is the world leader in robotic guided dentistry. The Neocis team is comprised of roboticists, engineers, and doctors with a successful history of commercializing medical robotics. Miami, FL

Neocis is the world leader in robotic guided dentistry. The Neocis team is comprised of roboticists, engineers, and doctors with a successful history of commercializing medical robotics.
Miami, FL

Accuitis, Inc. is engaged in the acquisition and development ofpharmaceuticals targeting niche, orphan, and underserved disease states. Atlanta, GA

Accuitis, Inc. is engaged in the acquisition and development ofpharmaceuticals targeting niche, orphan, and underserved disease states.
Atlanta, GA

NFANT Labs is a medical device and digital health company dedicated to improving the standard of care in infant feeding by providing medical products and services without prohibitive cost. Atlanta, GA

NFANT Labs is a medical device and digital health company dedicated to improving the standard of care in infant feeding by providing medical products and services without prohibitive cost.
Atlanta, GA

OcuCure is an ophthalmic pharmaceutical company developing new proprietary compounds with a focus on topical eye drops. Roanoke, VA

OcuCure is an ophthalmic pharmaceutical company developing new proprietary compounds with a focus on topical eye drops.
Roanoke, VA

Nephrogen is a medical device company dedicated to developing novel diagnostic tests for patients suffering from kidney disease and kidney failure. Atlanta, GA

Nephrogen is a medical device company dedicated to developing novel diagnostic tests for patients suffering from kidney disease and kidney failure.
Atlanta, GA

Mana Health is dedicated to streamlining data access, interoperability, and innovation in healthcare. New York, NY

Mana Health is dedicated to streamlining data access, interoperability, and innovation in healthcare.
New York, NY

Forus' proprietary technology is used to harvest a patient's own mesenchymal stem cells (MSCs)  leaving a highly concentrated stem cell solution, which is combined with bone graft material to repair and promote new bone growth in a patient. Minneapolis, MN

Forus' proprietary technology is used to harvest a patient's own mesenchymal stem cells (MSCs)  leaving a highly concentrated stem cell solution, which is combined with bone graft material to repair and promote new bone growth in a patient.
Minneapolis, MN